SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (5518)10/18/1998 4:07:00 PM
From: M. Alexander  Read Replies (1) of 6136
 
Hey all!
I'm not even a lurker I just walked in here, but I like Agouron as a long term product. However my knowledge may be very incomplete. I am a financial advisor who is just starting out and I am thinking of AGPH because it is a midcap and has earnings in a sector that I agree is interesting, but I am putting a Due Diligence report real quick for my compliance department as to what I see in this company and I don't have an answer as to why the last quarter was a loser.

What is the word? Anyone care to fill me in..and give me references...

is 220% mean consensu estimate accurate? Why is it so high? Europe?

Thanx all!
M. Alexander
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext